Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-25-001776
Filing Date
2025-12-08
Accepted
2025-12-08 16:39:10
Documents
1
Period of Report
2025-12-04

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 9236
  Complete submission text file 0000897069-25-001776.txt   10946
Mailing Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003
Business Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003 (516) 962-3186
Cambrian BioPharma Inc (Reporting) CIK: 0001797409 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 251556592

Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)